Amarin Corp Plc (AMRN)

[lettruthringout]

Because ICER previously conducted economic assessment on Vascepa.

All fine and dandy, but how the heck does V get on the "28 commonly used prescription drugs" list?

That's my guess anyway. They know what they intended for Vascepa (and the other drugs) when they did their previous assessments; they have their data from before; so are now targeting these same drugs with their new analyses. That is how they'll (hopefully) be able to provide results by October 20th.